Skip to main content
Sahil Parikh

Sahil Parikh

Director of Endovascular Services
Columbia University Irving Medical Center
After graduating magna cum laude with a bachelor’s degree in Biomedical Sciences and Engineering from Harvard College, Dr. Parikh earned his medical degree from The Johns Hopkins University School of Medicine, Baltimore, MD, with Phi Beta Kappa and Alpha Omega Alpha honors. He completed his internal medicine residency and chief residency at Massachusetts General Hospital; his cardiovascular medicine and interventional cardiology fellowships at Brigham and Women’s Hospital; and his vascular medicine and intervention fellowship at the Massachusetts General Hospital, Boston.  Following his training, in 2009, he was recruited to the Case Western University School of Medicine and University Hospitals Case Medical Center in Cleveland, OH where he was an Assistant Professor of Medicine and Director of the Center for Research and Innovation (Clinical Trials Center) and of the Interventional Cardiology Fellowship Program.  Thereafter, he was recruited in 2016 to serve as an Associate Professor of Medicine at the Columbia Vagelos College of Physicians and Surgeons and the Director of Endovascular Services at the Columbia University Irving Medical Center, both in New York. Dr. Parikh’s clinical practice leverages his knowledge and experience in clinical cardiovascular medicine and complex coronary and peripheral vascular interventions, with a focus on atherosclerotic vascular disease and intervention throughout the circulation. This includes coronary artery disease, peripheral arterial disease including claudication and critical limb ischemia, renovascular disease, cerebrovascular disease, and venous disease and thrombosis. Dr. Parikh is a nationally recognized clinician educator and investigator in vascular medicine and intervention. He has won numerous teaching awards locally and co-directs several national educational programs for physicians in training and for continuing medical education in conjunction with the Cardiovascular Research Foundation (CRF) where he is a co-director of TCT, the American College of Cardiology (ACC), and the Society for Cardiac Angiography and Intervention (SCAI). Dr. Parikh’s research interests center upon novel endovascular devices for the treatment of vascular disease. He has been the site, national or global principal investigator for dozens of clinical trials and has authored more than 175 original manuscripts and reviews in basic and clinical cardiovascular medicine.